|
Name |
Cuparene
|
Molecular Formula | C15H22 | |
IUPAC Name* |
1-methyl-4-[(1R)-1,2,2-trimethylcyclopentyl]benzene
|
|
SMILES |
CC1=CC=C(C=C1)[C@@]2(CCCC2(C)C)C
|
|
InChI |
InChI=1S/C15H22/c1-12-6-8-13(9-7-12)15(4)11-5-10-14(15,2)3/h6-9H,5,10-11H2,1-4H3/t15-/m0/s1
|
|
InChIKey |
SLKPBCXNFNIJSV-HNNXBMFYSA-N
|
|
Synonyms |
Cuparene; (+)-Cuparene; 16982-00-6; (R)-Cuparene; (R)-1-Methyl-4-(1,2,2-trimethylcyclopentyl)benzene; 1-methyl-4-[(1R)-1,2,2-trimethylcyclopentyl]benzene; (R)-(+)-p-(1,2,2-Trimethylcyclopentyl)toluene; Cuparene, (+)-; 56324-31-3; 24IR5X2B93; Benzene, 1-methyl-4-(1,2,2-trimethylcyclopentyl)-, (R)-; Toluene, p-(1,2,2-trimethylcyclopentyl)-, (R)-(+)-; UNII-24IR5X2B93; EINECS 241-061-5; 1-Methyl-4-(1,2,2-trimethylcyclopentyl)benzene #; (R)-1-(p-Tolyl)-1,2,2-trimethylcyclopentane; DTXSID70168762; CHEBI:167407; MFCD00043118; ZINC59778361; AKOS015914036; LMPR0103140001; SB46933; J-010581; (+)-Cuparene, >=99.0% (sum of enantiomers, GC); Q27253858; Benzene, 1-methyl-4-(1,2,2-trimethylcyclopentyl)-, (theta)-; BENZENE, 1-METHYL-4-(1,2,2-TRIMETHYLCYCLOPENTYL)-, (.THETA.)-
|
|
CAS | 16982-00-6 | |
PubChem CID | 86895 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 202.33 | ALogp: | 5.5 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.603 |
Caco-2 Permeability: | -4.563 | MDCK Permeability: | 0.00001110 |
Pgp-inhibitor: | 0.58 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.112 |
30% Bioavailability (F30%): | 0.242 |
Blood-Brain-Barrier Penetration (BBB): | 0.168 | Plasma Protein Binding (PPB): | 97.89% |
Volume Distribution (VD): | 2.617 | Fu: | 4.08% |
CYP1A2-inhibitor: | 0.501 | CYP1A2-substrate: | 0.931 |
CYP2C19-inhibitor: | 0.716 | CYP2C19-substrate: | 0.942 |
CYP2C9-inhibitor: | 0.424 | CYP2C9-substrate: | 0.839 |
CYP2D6-inhibitor: | 0.238 | CYP2D6-substrate: | 0.877 |
CYP3A4-inhibitor: | 0.549 | CYP3A4-substrate: | 0.569 |
Clearance (CL): | 4.024 | Half-life (T1/2): | 0.098 |
hERG Blockers: | 0.153 | Human Hepatotoxicity (H-HT): | 0.036 |
Drug-inuced Liver Injury (DILI): | 0.035 | AMES Toxicity: | 0.015 |
Rat Oral Acute Toxicity: | 0.085 | Maximum Recommended Daily Dose: | 0.064 |
Skin Sensitization: | 0.663 | Carcinogencity: | 0.109 |
Eye Corrosion: | 0.969 | Eye Irritation: | 0.988 |
Respiratory Toxicity: | 0.324 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001317 | 0.615 | D08KVZ | 0.373 | ||||
ENC001332 | 0.615 | D0X0WU | 0.296 | ||||
ENC000233 | 0.370 | D0N0RU | 0.276 | ||||
ENC000199 | 0.360 | D0P1UX | 0.260 | ||||
ENC000221 | 0.347 | D0M6DO | 0.257 | ||||
ENC001080 | 0.344 | D0O3FG | 0.253 | ||||
ENC002143 | 0.344 | D0H1QY | 0.250 | ||||
ENC000086 | 0.340 | D09FJB | 0.250 | ||||
ENC005925 | 0.324 | D0M2MR | 0.241 | ||||
ENC002280 | 0.314 | D0E8CI | 0.241 |